Physician profile
Naji Bourji
NPI 1235318056
$3,849.60
in general payments reported to CMS, 2019-2025
29 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $164 · 2021: $793 · 2022: $923 · 2023: $473 · 2024: $224 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,356.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $580.66 | 2019-2025 | Lifevest |
| Angiodynamics, INC. | $542.59 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $441.20 | 2019-2024 | Watchman Flx, Varithena Administration Pack |
| Abiomed | $276.43 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $255.36 | 2019-2022 | |
| Biotronik INC. | $193.75 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $186.05 | 2019-2022 | |
| Pfizer INC. | $181.21 | 2019-2025 | |
| Veryan Medical Incorporated | $167.11 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $152.03 | 2023-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $148.05 | 2019-2025 | Diamondback Peripheral |
| Amgen INC. | $109.09 | 2021-2023 | Repatha |
| Merck Sharp & Dohme LLC | $107.15 | 2021-2025 | Winrevair |
| Novartis Pharmaceuticals Corporation | $106.62 | 2020-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.35 | 2022-2023 | Jardiance |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $38.73 | 2019 | |
| Ge Healthcare | $37.21 | 2019 | |
| Intact Vascular, INC. | $34.47 | 2019 | |
| Medtronic, INC. | $27.48 | 2022 | |
| Inspire Medical Systems, INC. | $27.25 | 2025 | Inspire |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $26.55 | 2019 | |
| Tactile Systems Technology INC | $21.28 | 2025 | Nimbl, Flexitouch Plus |
| Advanced Respiratory, INC | $21.24 | 2021 | |
| Alnylam Pharmaceuticals INC. | $19.88 | 2025 | Amvuttra |
| Sequel Med Tech, LLC | $18.75 | 2025 | Twiist |
| Elutia, INC. | $17.80 | 2024 | Ecm Patch,Pouch |
| Bayer Healthcare Pharmaceuticals INC. | $16.92 | 2025 | |
| Lantheus Medical Imaging, INC. | $16.58 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naji Bourji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.